0001104659-22-084988.txt : 20220802
0001104659-22-084988.hdr.sgml : 20220802
20220802085117
ACCESSION NUMBER: 0001104659-22-084988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20220802
DATE AS OF CHANGE: 20220802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morabito Christopher
CENTRAL INDEX KEY: 0001859284
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 221126998
MAIL ADDRESS:
STREET 1: C/O FULCRUM THERAPEUTICS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astria Therapeutics, Inc.
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090127
4
1
tm2222284-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-08-01
0
0001454789
Astria Therapeutics, Inc.
ATXS
0001859284
Morabito Christopher
75 STATE STREET
SUITE 1400
BOSTON
MA
02109
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
3.87
2022-08-01
4
A
0
100000
0
A
2032-07-31
Common Stock
100000
100000
D
The option was granted on August 1, 2022, pursuant to the Astria Therapeutics, Inc. 2022 Inducement Stock Incentive Plan and the terms and conditions of an award agreement covering the option grant. This option is subject to vesting over a four year period, with 25% of shares vesting on the first anniversary of July 14, 2022, the reporting person's employment start date, and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Ben Harshbarger, as attorney-in-fact for Christopher J. Morabito
2022-08-02